The Group's principal activity is developing products for the treatment of cancer and stem cell derived therapies for the brain. It operates through three segments: Oncology Products, Drug Delivery and CellMed. The Group operates in the United States, Europe and Rest of the World. On 01-Aug-2008, the Group acquired BrachySciences Inc. and its affiliated companies.
Alacra Alerts:
Receive alerts on the latest reports on Biocompatibles International plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
